24/7
Buzz
Startups
VC
AI
DefenseTech
Opinions
Events
ScaleUp House
Promising Startups 2026
2026 VC Survey
Boarding Pass
CTalk
BiblioTech
Appointments
Tech Gateways
HR - The Next Leap
Ctech Testimonials
Projects
About
Newsletter
Contact us
Facebook
Twitter
ACCESSIBILITY
by
Homepage
Boehringer Ingelheim
Tags search
HOME
24/7
buzz
STARTUPS
VC
AI
DefenseTech
OPINIONS
ScaleUp House
EVENTS
Projects
ABOUT
teram of use
Privacy Policy
NEWSLETTER
SEARCH
CONTACT US
ACCESSIBILITY
24/7
Headlines
21:15
OpenWeb seeks insolvency protection as former Israeli unicorn faces cash-flow crisis
20:45
Paragon co-founder Idan Nurik to leave and launch AI infrastructure startup
19:35
Prime Minister’s Office and Finance Ministry oppose $4.2 billion Zim sale
18:32
Melisron CEO Ophir Sarid dies at 54 after sudden illness
More stories
Buzz
Most popular
Daily
Weekly
1
Oracle’s co-CEOs got $350 million in equity awards. A year later, the stock had lost half its value
2
Intel has 70 people working on quantum computing. Its CEO is betting on the next frontier
3
Assaf Rappaport: “I received an envelope with $30 billion written on it. I said no right away”
4
Intel CEO says he uses AI agents every day to cut hours of research to minutes
5
U.S. bank Valley National buys Israeli fintech Bluevine for $340 million
More news
Boehringer Ingelheim
1 stories about Boehringer Ingelheim
Immunai signs up to $15 million research pact with Boehringer Ingelheim
25.06.26
|
CTech
The collaboration focuses on decoding T-cell dysfunction, a common thread linking cancer and autoimmune disorders.